Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0011306,
umls-concept:C0033684,
umls-concept:C0041904,
umls-concept:C0085424,
umls-concept:C0123759,
umls-concept:C0162493,
umls-concept:C0206431,
umls-concept:C0243144,
umls-concept:C0262950,
umls-concept:C0439590,
umls-concept:C0600251,
umls-concept:C1274040,
umls-concept:C1427559,
umls-concept:C1444748
|
pubmed:issue |
6
|
pubmed:dateCreated |
1995-8-22
|
pubmed:abstractText |
Dendritic cells synthesize and express major histocompatibility complex (MHC) class II peptide-binding elements constitutively and, therefore, belong to the category of professional antigen-presenting cells. Unlike other cells that show constitutive class II expression, such as B cells and certain T cell clones, dendritic cells possess the unique capacity to activate naive T cells. Using dendritic cells generated in vitro by culture of mouse bone marrow in the presence of low doses of recombinant mouse granulocyte/macrophage colony-stimulating factor, we found that discrete maturation stages of these cells can be distinguished which were correlated with defined functional capabilities. The striking observation was the presence of a progenitor dendritic cell expressing low levels of class II which, unlike its differentiated counterpart in vitro, possessed pronounced phagocytic activity. Adding protein antigen to dendritic cells in a particle-adsorbed form, as compared to a soluble form, we demonstrate that phagocytosis of the particle-adsorbed protein by progenitor dendritic cells involves an activation event. This is evidenced by the de novo synthesis of transcripts of interleukin-1 alpha and interleukin-12 p40/p35 as well as transcripts of MHC class II. Most importantly, an augmented and prolonged antigen-presentation capacity was observed when the antigen was given in particle-adsorbed instead of soluble form. These findings indicate that progenitor dendritic cells are functionally more flexible and potent than fully differentiated dendritic cells and that they play a crucial role in antigen presentation. It is suggested that these findings will open up new possibilities to devise strategies for vaccine development.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1566-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7614984-Animals,
pubmed-meshheading:7614984-Antigen Presentation,
pubmed-meshheading:7614984-Bone Marrow,
pubmed-meshheading:7614984-Bone Marrow Cells,
pubmed-meshheading:7614984-Cells, Cultured,
pubmed-meshheading:7614984-Dendritic Cells,
pubmed-meshheading:7614984-Histocompatibility Antigens Class II,
pubmed-meshheading:7614984-Interleukin-1,
pubmed-meshheading:7614984-Interleukin-12,
pubmed-meshheading:7614984-Male,
pubmed-meshheading:7614984-Mice,
pubmed-meshheading:7614984-Mice, Inbred C3H,
pubmed-meshheading:7614984-Phagocytosis,
pubmed-meshheading:7614984-Up-Regulation
|
pubmed:year |
1995
|
pubmed:articleTitle |
Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation.
|
pubmed:affiliation |
Institute of Immunology, Johannes-Gutenberg-University, Mainz, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|